Hangzhou Tigermed Consulting Co., Ltd.
HNGZY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3 | $25 | $25 | $25 |
| - Cash | $0 | $2 | $2 | $2 |
| + Debt | $0 | $2 | $3 | $3 |
| Enterprise Value | $3 | $26 | $27 | $26 |
| Revenue | $0 | $2 | $2 | $2 |
| % Growth | -85.3% | 7.8% | 1.9% | – |
| Gross Profit | $0 | $1 | $0 | $0 |
| % Margin | 27.5% | 30.1% | 30% | 17.7% |
| EBITDA | $0 | $0 | $0 | -$0 |
| % Margin | 44.7% | 18.4% | 12% | -18.8% |
| Net Income | $0 | $0 | $0 | -$0 |
| % Margin | 35.9% | 12.9% | 10.6% | -26.6% |
| EPS Diluted | 0.1 | 0.25 | 0.19 | -0.47 |
| % Growth | -60% | 31.6% | 140.4% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |